Top Markets
Coin of the day
Apontis Pharma AG Apontis Pharma AG

Apontis Pharma AG

APPH
Rank in Stocks #21489
Operating within Germany, Apontis Pharma AG specializes in the marketing and... Operating within Germany, Apontis Pharma AG specializes in the marketing and distribution of pharmaceutical products, with a particular emphasis on internal medicine. The company is actively involved in the development, promotion, and commercialization of a diverse portfolio, which includes combination single-pill therapies and other medications. Key therapeutic areas of focus encompass cardiovascular diseases, such as high blood pressure (hypertension), elevated cholesterol (hyperlipidemia), and strategies for secondary prevention, in addition to respiratory ailments and diabetes. Established in 1946, Apontis Pharma AG maintains its corporate headquarters in Monheim am Rhein, Germany.
Share Price
$12.75
Last synced: 2025-11-17
Market Cap
$106.20M
Change (1 day)
-2.29%
Change (1 year)
0.24%
Country
DE
Trade Apontis Pharma AG (APPH)

Category

Operating Margin for Apontis Pharma AG (APPH)
Operating Margin as of 2026 TTM: 0.00%
According to Apontis Pharma AG latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Apontis Pharma AG from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
DE
0.00% -
DE
0.00% -
JP
0.00% -
CH
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.